Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liu Wei Di Huang Capsule for Yin-deficient type 2 diabetes mellitus
ChiCTR2200065180Phase 2Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Nov 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and Yin Deficiency (YD) comparing Liu Wei Di Huang Capsule + basic treatment with Placebo + basic treatment (2 arms). Primary endpoints: Traditional Chinese medicine syndrome score, Fasting blood glucose (FBG) and 2 more. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
liu wei di huang wan
03
Conditions
type 2 diabetes mellitus (T2DM)Yin Deficiency (YD)
Beyond the preview
Go deeper on ChiCTR2200065180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065180.